Applying a Chatbot to Geriatric Patients in Psychiatric Clinics: A Pilot Study
22 de septiembre de 2021 actualizado por: Chang Gung Memorial Hospital
This study will use the caring chatbot developed by the Taipei University of Technology team to provide care for participants and use robots to talk to them to collect daily changes in mood, sleep, and activities, and analyze the factors that affect the physical and mental health of the elderly.
Descripción general del estudio
Estado
Aún no reclutando
Condiciones
Intervención / Tratamiento
Descripción detallada
The prevalence of anxiety and depression in middle-aged and elderly people is quite high. Among the risk factors for illness, "loneliness" is closely related to the physical and mental health of the elderly: the higher the loneliness of the elderly, the more likely to develop unhealthy lifestyle habits and emotional symptoms such as depression and anxiety. Depression and anxiety are often comorbid, and the diagnoses of the two groups have many symptoms that overlap each other. Emotional symptoms that have not been effectively treated have a great impact on the quality of life, and the drug treatment of emotional disorders in the elderly is more difficult. In addition to medication, maintaining a healthy lifestyle is also conducive to the control of emotional disorders.
Information technology has been used in supplementary medical care and maintenance of physical and mental health for decades. However, reviewing the literature, there is less research on applications developed in cooperation between the information field and the field of psychiatric medical care, and there are no applications developed for the mental health of middle-aged and elderly people.
This study will use the caring chatbot developed by the National Taipei University of Technology team to provide care for the participants enrolled from the psychiatric outpatient department, and use the chatbot to talk to them to collect daily changes in mood, sleep, and activities, and analyze the factors that affect the mental health of the elderly.
This research anticipates the following goals:
- With the chatbot developed, it provides care for subjects every day and collects their daily changes in mood, sleep, and activities.
- Analyze the relationship between robot interaction and emotional changes, and evaluate the impact of chatbot intervention on the health behavior of the case.
Tipo de estudio
Intervencionista
Inscripción (Anticipado)
75
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Ya-Hsin Chou, MD
- Número de teléfono: 2485 (03)3281288
- Correo electrónico: b9302015@cgmh.org.tw
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
55 años a 110 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- with the diagnosis of persistent depressive disorder, major depressive disorder, general anxiety disorder, panic disorder, or agoraphobia
- the condition of their disease is relatively stable (defined as no thought of death and no medication adjustment in the recent 3 months).
- Have a personal mobile phone or communicator that can connect to the Internet
Exclusion Criteria:
- Those who are unwilling to participate in this research
- Those who have poor assessment ability by clinicians and cannot understand the content of the questionnaire; or those who cannot continue to complete the test due to their physical condition
- Comorbid schizophrenia or bipolar disorder
- Patients with dementia, brain injury, substance abuse, and stroke
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: caring chatbot
The investigators will enroll participants aged over 55 in the psychiatric outpatient department.
The participants will get a one-month caring chatbot and can interact with the chatbot freely.
|
The investigators will use the developed caring chatbot to provide care to the cases and to collect case treatment data and interaction data between the case and the caring chatbot.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
acceptance measured by seven-point Likert scales
Periodo de tiempo: at the end of one-month-intervention of the caring chatbot
|
Satisfacation (How satisfied were you with Chatbot?), usability (How easy was talking to Chatbot?), continue (How much would you like to continue working with Chatbot?) and adherence (How likely is it that you will follow Chatbot's advice?) were measured by single items on seven-point Likert scales (with 1= "not at all" and 7="very much").
|
at the end of one-month-intervention of the caring chatbot
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change from baseline "loneliness" measured by UCLA Loneliness Scale
Periodo de tiempo: before and at the end of one-month-intervention of the caring chatbot
|
The UCLA Loneliness Scale (version 3) is a 20-item measure that assesses how often a person feels disconnected from others.
Using a 4-point rating scale (1= never; 4 = always), participants answer 20 questions, and researchers later reverse-code the positively worded items so that high values mean more loneliness.
|
before and at the end of one-month-intervention of the caring chatbot
|
|
Change from baseline "depression" measured by Geriatric Depression Scale-Short Form (GDS-15)
Periodo de tiempo: before and at the end of one-month-intervention of the caring chatbot
|
Geriatric Depression Scale (GDS) is designed for the older population.
A Short Form GDS consisting of 15 questions.
Of the 15 items, 10 indicated the presence of depression when answered positively, while the rest indicated depression when answered negatively.
Scores of 5-8 indicate mild depression; 9-11 indicate moderate depression; 12-15 indicate severe depression.
|
before and at the end of one-month-intervention of the caring chatbot
|
|
Change from baseline "anxiety" measured by Hospital Anxiety and Depression Scale- Anxiety subscale
Periodo de tiempo: before and at the end of one-month-intervention of the caring chatbot
|
Hospital Anxiety and Depression Scale (HADS) is developed for people with physical illnesses.
This scale includes a total of 14 questions.
There are 7 questions about anxiety and depression, each with a 4-point scoring method (0-3 points).
The higher the total score, the greater the anxiety or the greater the depression.
Due to the high overlap between the topics of the depression subscale and the GDS, this study only uses the anxiety subscale.
|
before and at the end of one-month-intervention of the caring chatbot
|
|
Change from baseline "quality of life" measured by Short Form Quality Life Sale (SF-12)
Periodo de tiempo: before and at the end of one-month-intervention of the caring chatbot
|
Short Form Quality Life Sale (SF-12) is the most commonly used questionnaire in the study of the quality of life of the elderly, with a total score ranging from 13~43.
A higher score reflects a better life quality.
|
before and at the end of one-month-intervention of the caring chatbot
|
|
Change from baseline "physical activity" measured by International Physical Activity Questionnaire Self-Administered Short Version (IPAQ-SS)
Periodo de tiempo: before and at the end of one-month-intervention of the caring chatbot
|
International Physical Activity Questionnaire Self-Administered Short Version (IPAQ-SS) measures the physical activity of the participant in the past seven days by self-filled method.
The questionnaire is consisted of four domains: (1)during transportation, (2) at work, (3) during household and gardening tasks and (4) during leisure time, including exercise and sport participation.
In each of the four domains the number of days per week and time per day spent in both moderate and vigorous activity are recorded.
|
before and at the end of one-month-intervention of the caring chatbot
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Anticipado)
27 de septiembre de 2021
Finalización primaria (Anticipado)
31 de enero de 2022
Finalización del estudio (Anticipado)
31 de julio de 2022
Fechas de registro del estudio
Enviado por primera vez
1 de septiembre de 2021
Primero enviado que cumplió con los criterios de control de calidad
22 de septiembre de 2021
Publicado por primera vez (Actual)
23 de septiembre de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
23 de septiembre de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
22 de septiembre de 2021
Última verificación
1 de agosto de 2021
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 202001915B0C601
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre caring chatbot
-
St. Luke's Health System, Boise, IdahoPatient-Centered Outcomes Research Institute; University of Washington; Idaho Suicide...TerminadoCOVID-19 | Salud mentalEstados Unidos
-
Yonsei UniversityTerminadoNeoplasias de mamaCorea, república de
-
University of Maryland, College ParkTerminadoCáncer de cuello uterino | Cáncer de ano | Cáncer de peneEstados Unidos
-
Abramson Cancer Center at Penn MedicineReclutamientoCáncer de cabeza y cuello | Cáncer de pulmón | Cáncer gastrointestinalEstados Unidos
-
University of DelawareReclutamientoInsomnio | Síndrome metabólico | La privación del sueñoEstados Unidos
-
University of VirginiaUniversity of ArizonaAún no reclutandoSupervivencia | Neoplasia de cabeza y cuello
-
Ankara Medipol UniversityTerminado
-
Adonis Hijaz, MDReclutamientoIncontinencia urinariaEstados Unidos
-
National Taiwan Normal UniversityTerminadoEnfermedad Renal CrónicaTaiwán
-
Collinge and Associates, Inc.National Cancer Institute (NCI)Terminado